Procter & Gamble (NYSE:PG) Shares Down 0.7%

The Procter & Gamble Company (NYSE:PG - Get Free Report) shares dropped 0.7% during mid-day trading on Friday . The stock traded as low as $162.16 and last traded at $162.69. Approximately 1,507,384 shares were traded during trading, a decline of 78% from the average daily volume of 6,868,543 shares. The stock had previously closed at $163.84.

Analysts Set New Price Targets

PG has been the subject of a number of analyst reports. Raymond James raised their price target on Procter & Gamble from $170.00 to $175.00 and gave the company an "outperform" rating in a research note on Wednesday, January 24th. Barclays boosted their price target on Procter & Gamble from $168.00 to $170.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 23rd. Truist Financial raised Procter & Gamble from a "hold" rating to a "buy" rating and raised their price objective for the company from $160.00 to $175.00 in a research report on Monday, March 11th. Royal Bank of Canada increased their price target on Procter & Gamble from $156.00 to $157.00 and gave the company a "sector perform" rating in a research note on Wednesday, January 24th. Finally, Jefferies Financial Group lifted their price objective on shares of Procter & Gamble from $175.00 to $182.00 and gave the stock a "buy" rating in a research report on Monday, April 22nd. Seven research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $169.76.


Get Our Latest Stock Analysis on PG

Procter & Gamble Stock Up 0.4 %

The company has a market cap of $388.15 billion, a P/E ratio of 26.87, a PEG ratio of 3.32 and a beta of 0.43. The stock has a 50-day moving average of $159.94 and a 200 day moving average of $154.04. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.69 and a quick ratio of 0.48.

Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Friday, April 19th. The company reported $1.52 EPS for the quarter, beating the consensus estimate of $1.42 by $0.10. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The firm had revenue of $20.20 billion for the quarter, compared to analyst estimates of $20.43 billion. During the same period last year, the firm earned $1.37 EPS. The business's quarterly revenue was up .6% compared to the same quarter last year. Research analysts anticipate that The Procter & Gamble Company will post 6.55 earnings per share for the current year.

Procter & Gamble Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.45%. The ex-dividend date of this dividend is Thursday, April 18th. This is an increase from Procter & Gamble's previous quarterly dividend of $0.94. Procter & Gamble's dividend payout ratio (DPR) is currently 65.69%.

Insider Transactions at Procter & Gamble

In other news, COO Shailesh Jejurikar sold 31,000 shares of the stock in a transaction dated Tuesday, April 30th. The shares were sold at an average price of $162.90, for a total value of $5,049,900.00. Following the completion of the transaction, the chief operating officer now owns 9,739 shares of the company's stock, valued at $1,586,483.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Procter & Gamble news, insider Balaji Purushothaman sold 28,369 shares of the company's stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total value of $4,581,309.81. Following the completion of the transaction, the insider now owns 11,507 shares of the company's stock, valued at approximately $1,858,265.43. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Shailesh Jejurikar sold 31,000 shares of Procter & Gamble stock in a transaction dated Tuesday, April 30th. The shares were sold at an average price of $162.90, for a total value of $5,049,900.00. Following the sale, the chief operating officer now directly owns 9,739 shares in the company, valued at $1,586,483.10. The disclosure for this sale can be found here. In the last quarter, insiders sold 86,865 shares of company stock valued at $14,059,180. Corporate insiders own 0.17% of the company's stock.

Institutional Investors Weigh In On Procter & Gamble

Several hedge funds have recently added to or reduced their stakes in the business. Moreno Evelyn V lifted its position in shares of Procter & Gamble by 1.9% in the 3rd quarter. Moreno Evelyn V now owns 54,345 shares of the company's stock worth $7,927,000 after purchasing an additional 1,037 shares during the period. Nixon Peabody Trust Co. boosted its position in Procter & Gamble by 0.7% during the third quarter. Nixon Peabody Trust Co. now owns 13,886 shares of the company's stock valued at $2,025,000 after acquiring an additional 100 shares during the last quarter. Cohen Lawrence B grew its holdings in Procter & Gamble by 5.9% during the 3rd quarter. Cohen Lawrence B now owns 20,384 shares of the company's stock worth $2,973,000 after acquiring an additional 1,135 shares during the period. Busey Trust CO lifted its stake in shares of Procter & Gamble by 0.6% in the 3rd quarter. Busey Trust CO now owns 194,111 shares of the company's stock valued at $28,313,000 after purchasing an additional 1,233 shares during the period. Finally, RMR Wealth Builders boosted its position in shares of Procter & Gamble by 51.6% during the 3rd quarter. RMR Wealth Builders now owns 8,727 shares of the company's stock valued at $1,273,000 after purchasing an additional 2,971 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Company Profile

(Get Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Procter & Gamble right now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Featured Articles and Offers

Search Headlines: